RAG2 Gene Combined Cellular and Humoral Immune Defects with Granulomas Genetic Test
Welcome to DNA Labs UAE, where we offer the RAG2 Gene Combined Cellular and Humoral Immune Defects with Granulomas Genetic Test. This test is designed to diagnose individuals with combined cellular and humoral immune defects caused by mutations in the RAG2 gene. The test is priced at AED 4400.0 and can be performed using a blood sample, extracted DNA, or one drop of blood on an FTA card. Results are typically delivered within 3 to 4 weeks using NGS technology.
Test Details
The RAG2 gene is responsible for encoding the RAG2 protein, which plays a crucial role in the development and function of the immune system. Mutations in the RAG2 gene can lead to combined cellular and humoral immune defects with granulomas. Combined cellular and humoral immune defects refer to a condition where both the cellular and humoral components of the immune system are affected. The cellular immune system is responsible for the recognition and elimination of infected or cancerous cells, while the humoral immune system is involved in the production of antibodies to fight against pathogens.
Granulomas are small areas of inflammation that can form in various tissues of the body, typically in response to chronic infections or immune system disorders. In the context of RAG2 gene mutations, the presence of granulomas suggests that the immune system is unable to effectively eliminate infections, leading to the formation of these inflammatory nodules.
NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously and identify genetic variations or mutations. In the case of RAG2 gene defects, NGS genetic testing can be used to identify specific mutations in the RAG2 gene that may be responsible for the combined cellular and humoral immune defects with granulomas. This information can help in diagnosing the condition and guiding appropriate treatment options.
Pre Test Information
Before undergoing the RAG2 Gene Combined Cellular and Humoral Immune Defects with Granulomas Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by RAG2 gene mutations. This will help in understanding the inheritance pattern and identifying individuals at risk of developing the condition.
Test Department
The RAG2 Gene Combined Cellular and Humoral Immune Defects with Granulomas Genetic Test is conducted in our Genetics department.
Doctor
The test is recommended by dermatologists, as they specialize in the diagnosis and treatment of skin disorders.
Test Name | RAG2 Gene Combined cellular and humoral immune defects with granulomas Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Osteology Dermatology Immunology Disorders |
Doctor | Dermatologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for RAG2 Gene Combined cellular and humoral immune defects with granulomas NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with RAG2 Gene Combined cellular and humoral immune defects with granulomas NGS Genetic DNA Test gene RAG2 |
Test Details |
The RAG2 gene is responsible for encoding the RAG2 protein, which plays a crucial role in the development and function of the immune system. Mutations in the RAG2 gene can lead to combined cellular and humoral immune defects with granulomas. Combined cellular and humoral immune defects refer to a condition where both the cellular and humoral components of the immune system are affected. The cellular immune system is responsible for the recognition and elimination of infected or cancerous cells, while the humoral immune system is involved in the production of antibodies to fight against pathogens. Granulomas are small areas of inflammation that can form in various tissues of the body, typically in response to chronic infections or immune system disorders. In the context of RAG2 gene mutations, the presence of granulomas suggests that the immune system is unable to effectively eliminate infections, leading to the formation of these inflammatory nodules. NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously and identify genetic variations or mutations. In the case of RAG2 gene defects, NGS genetic testing can be used to identify specific mutations in the RAG2 gene that may be responsible for the combined cellular and humoral immune defects with granulomas. This information can help in diagnosing the condition and guiding appropriate treatment options. |